P59 Antitumor response of preclinical tumor models to IGF-IR targeted therapy is not dependent on PTEN or PIK3CA mutational status
| Autor: | Deevi, D.S., Burtrum, D., Novosyadlyy, R., Tonra, J.R., Ludwig, D.L. |
|---|---|
| Zdroj: | In Growth Hormone & IGF Research 2010 20 Supplement 1:S60-S60 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect